BackForward Pharma A/S Overview

Forward Pharma A/S Net Income

Track Forward Pharma A/S's net income ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

$6.48M

As of Dec 2021

Annual Net Income (TTM)

$0
100% YoY

Trailing 12 months ending Dec 2021

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Forward Pharma A/S (FWP) FAQ

Forward Pharma A/S (FWP) currently reports a net income of $0 as of December 2021. That compares with $910M in the prior-year period — down 100.0% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Forward Pharma A/S's net income history and peer comparisons.

Forward Pharma A/S's net income decreased from $910M to $0 — a 100.0% year-over-year decrease (period ending December 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Forward Pharma A/S's net income of $0 is lower than the Healthcare sector average of $16B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Forward Pharma A/S reported $0 in net income as of December 2021. That compares with $910M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Forward Pharma A/S, and consider following FWP for alerts when major investors trade the stock.